Testing effectiveness (Phase 2)Study completedNCT01261247
What this trial is testing
Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more
Mayo Clinic 41